Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y

P2Y12 antagonist adenosine receptor adenosine receptor agonist anti-platelet therapy platelet

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
31 Jul 2020
Historique:
received: 30 06 2020
revised: 30 07 2020
accepted: 30 07 2020
entrez: 6 8 2020
pubmed: 6 8 2020
medline: 6 8 2020
Statut: epublish

Résumé

We have shown previously that platelet activity can be lowered through the simultaneous inhibition of P2Y

Identifiants

pubmed: 32752089
pii: ph13080177
doi: 10.3390/ph13080177
pmc: PMC7464091
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fundacja na rzecz Nauki Polskiej
ID : TEAM/2016-1/8
Organisme : National Science Centre - Poland
ID : 2019/32/T/NZ3/00333 ETIUDA7

Références

Thromb Res. 2011 Sep;128(3):243-50
pubmed: 21600632
Handb Exp Pharmacol. 2009;(193):215-69
pubmed: 19639284
Thromb Haemost. 2014 Jan;111(1):3-7
pubmed: 24285121
Thromb Res. 1986 Jul 15;43(2):161-75
pubmed: 3016942
Naunyn Schmiedebergs Arch Pharmacol. 1994 Jun;349(6):644-50
pubmed: 7969516
Vascul Pharmacol. 2019 Feb;113:47-56
pubmed: 30471364
J Neurochem. 1979 Nov;33(5):999-1005
pubmed: 228008
BMJ. 2019 Feb 28;364:l895
pubmed: 30819687
Eur Heart J. 2018 Jan 14;39(3):213-260
pubmed: 28886622
Nature. 1964 Apr 4;202:95-6
pubmed: 14166734
Nat Rev Drug Discov. 2013 Apr;12(4):265-86
pubmed: 23535933
PLoS One. 2014 Nov 13;9(11):e112741
pubmed: 25393959
Med Chem. 2016;12(2):131-8
pubmed: 26411604
Br J Pharmacol. 2000 Jan;129(1):2-11
pubmed: 10694196
J Med Chem. 1994 May 27;37(11):1720-6
pubmed: 8201607
Hematology Am Soc Hematol Educ Program. 2011;2011:51-61
pubmed: 22160012
Pharm Acta Helv. 1993 Sep;68(2):77-111
pubmed: 8234392
Ann N Y Acad Sci. 2001;936:340-54
pubmed: 11460491
Exp Cell Res. 2010 May 1;316(8):1284-8
pubmed: 20153317
Molecules. 2019 Dec 28;25(1):
pubmed: 31905703
J Am Coll Cardiol. 2017 Oct 3;70(14):1760-1776
pubmed: 28958334
Int J Mol Sci. 2019 Nov 03;20(21):
pubmed: 31684173
Biochim Biophys Acta. 2011 May;1808(5):1290-308
pubmed: 21185259
J Med Chem. 2007 Mar 22;50(6):1222-30
pubmed: 17309246
Curr Pharm Des. 2004;10(14):1567-76
pubmed: 15134555
Nat Rev Drug Discov. 2006 Mar;5(3):247-64
pubmed: 16518376
Blood Coagul Fibrinolysis. 2006 Mar;17(2):113-24
pubmed: 16479193
Curr Pharm Des. 2019;25(26):2892-2905
pubmed: 31333104
Curr Med Chem. 2010;17(26):2897-905
pubmed: 20858171
Platelets. 2015;26(2):168-76
pubmed: 24679412
EMBO J. 1999 Jan 4;18(1):37-48
pubmed: 9878048
Nature. 2014 Dec 18;516(7531):395-9
pubmed: 25317558
Drug Discov Today. 2019 Jan;24(1):325-333
pubmed: 30291899
Platelets. 2018 May;29(3):292-300
pubmed: 28504052
Rapid Commun Mass Spectrom. 2007;21(2):169-79
pubmed: 17154350
Purinergic Signal. 2011 Sep;7(3):357-65
pubmed: 21484090
Pharmacol Rep. 2005 Jan-Feb;57(1):1-13
pubmed: 15849372
Int J Mol Sci. 2014 Jan 28;15(2):2024-52
pubmed: 24477263
Expert Opin Drug Metab Toxicol. 2018 Mar;14(3):303-315
pubmed: 29338536
Front Biosci (Landmark Ed). 2011 Jun 01;16:2172-86
pubmed: 21622169
Nat Rev Drug Discov. 2008 Sep;7(9):759-70
pubmed: 18758473
Saudi Pharm J. 2013 Jul;21(3):245-53
pubmed: 23960840
Mol Pharmacol. 1990 Jun;37(6):870-5
pubmed: 2359405

Auteurs

Nina Wolska (N)

Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Sciences, Faculty of Health Sciences, Medical University of Lodz, Mazowiecka 6/8, 92-235 Lodz, Poland.

Hassan Kassassir (H)

Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Sciences, Faculty of Health Sciences, Medical University of Lodz, Mazowiecka 6/8, 92-235 Lodz, Poland.

Boguslawa Luzak (B)

Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Sciences, Faculty of Health Sciences, Medical University of Lodz, Mazowiecka 6/8, 92-235 Lodz, Poland.

Cezary Watala (C)

Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Sciences, Faculty of Health Sciences, Medical University of Lodz, Mazowiecka 6/8, 92-235 Lodz, Poland.

Marcin Rozalski (M)

Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Sciences, Faculty of Health Sciences, Medical University of Lodz, Mazowiecka 6/8, 92-235 Lodz, Poland.

Classifications MeSH